We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Xcounter | XCT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 275.00 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 275.00 |
| Top Posts |
|---|
Posted at 22/1/2010 06:20 by buystock a reply 2 my posts on the lse this will be massively pIMO... it is true what you say... it is not far off... the dates you mention coincide with what i seem to be digging up.. the German government was amongst the first to protect their country from a deeper rescission. Lending and supporting thier companies is something a friend of mine told me is very common. He too is German citizen and runs 4 business's.. ranging from a property lettings agency to an off license and says that he had to pay a 0.05% sum as a form of application in 1998 ( which was the most recent time he had applied) of the sum he had looked to be borrowing, and also believes the same still applies. So with this in mind Artemis would have had to shell out a small fortune to some, in order to gain the grant. He also explained its a process that takes a small amount of time and effort, involving accountants and company draft's and forecast's, also plan's on how the money will be used and spent. Meaning Artemis would have already done this which is time, effort and cost, and a company like this with the resources it has to me, doesn't seem like they would waste time applying for a grant when going to the banks for a lender is far easyier and simpler. Being a medical company this gives more of a chance of obtaining the grant, and also some sort of negotiated grant at worst. So i do see this happening and quick. I also believe that Any take over will happen after the grant has been obtained, and only half the company would go as have the shares now belong to the directors, other investors and even staff member's who cannot sell till they leave, if im correct? if was to be offered 50p+ for each share i own, i'd be happy enough, but would be disappointed not to be here for the bigger pay day.. it will be intresting to see what happens apon grant approval and then on the start of the R&D phase.. which i believe may be almost instant, seem to me there is a lot to look forward to over the next 10 or so trading days and even over the next 1-3 years... but short term this has the potential to become one of those share that people see have a 3-400% jump in an instant and start to get involved... im sure ill be proved to be right.. Ive tried tipping this to 3 or 4 people, but there not interested in something new.. Again i strongly credit you on a great find.. And seems i will owe you a drink very soon... Just to add i think the 2 trades i have placed here of around 21-22 thousand shares, should show tomorrow... Hargreaves landsdown show the market cap at over 7 mio... so i think also the new share will show tomorrow and see a small rise in anticipation of the week/s ahead.. As alwas your thoughts and anyone else's welcome.. Look forward to reading a morning post tomorrow.opular very very soon. |
Posted at 24/12/2009 06:59 by buystock sharecrazy newsletter WHITEHORSE CAPITAL increase stake 11% jan bid 50p+ BOARD TALK =down&startMid=0&has--- On Wed, 23/12/09, ShareCrazy.com wrote: Stockholm, 22 December 2009 XCounter notification of changes in significant shareholdings XCounter AB (AIM: XCT) ("XCounter"), a technology leader in the development of photon counting X-ray detectors and tomosynthesis based 3D medical imaging, announces today that it has received notification from Whitehorse Investing Ltd ("Whitehorse") that on the 21st December 2009 it purchased 734,786 XCounter shares taking its total shareholding to 4,834,786 shares which represents 11.1 % of XCounter RNS Number : 5662D XCounter AB 03 December 2009 PRESS RELEASE Stockholm, 03 December 2009 XCounter notification of changes in significant shareholdings XCounter AB (AIM: XCT) ("XCounter"), a technology leader in the development of photon counting X-ray detectors and tomosynthesis based 3D medical imaging, announces it has received notification from Whitehorse Investing Ltd ("Whitehorse") that it has purchased 4,100,000 XCounter shares representing 9.41 % of the issued share capital of XCounter, from HealthCap. The Company has also received notification that funds managed by HealthCap have sold in aggregate 5,476,487 XCounter shares, representing 12.57% of the share capital in XCounter. Whitehorse is an investor in a commercial partner of Oy Ajat Ltd, a company in which XCounter owns 49.8% and owns a call option for the remaining 50.2% |
Posted at 23/12/2009 04:31 by buystock About Whitehorse CapitalWhitehorse Capital is a privately held investment firm focused on acquiring and managing technology businesses. Whitehorse Capital prefers to acquire these businesses through corporate divestiture and private sales. Backed by the capital and expertise of its founders, our acquisition and investment strategy is to target companies with revenues that range from $5 million to $50 million, and encourage their growth and development in an entrepreneurial and rewarding environment. Key facts ◦The company and its affiliates have been active investors in technology since 1995. ◦Our portfolio is built around technology companies in software, hardware, telecommunications, operations and transaction management services. ◦Our acquisitions serve a customer base of millions of individual and corporate customers worldwide. ◦With the expertise and capability to manage for growth and profit, our management is focused on creating sustainable, world-class businesses. ◦Whitehorse Capital has offices in Los Angeles and London. People The Whitehorse Capital team has extensive experience in the management and development of large and profitable technology businesses in Europe, the USA and the Australia/Pacific region. [top] Whitehorse Capital's investment strategy is built around a simple philosophy that looks to create value for investors by giving management the freedom to execute commercial strategies within a well defined strategic framework that focuses on core competencies. Philosophy Our investment philosophy centres on partnering with entrepreneurs who have the vision, character, and ambition needed to grow exceptional companies. We put our emphasis on assisting entrepreneurs develop companies that have proven products and have the potential to become leaders in their industry sectors. Criteria Whitehorse Capital does not invest in first round or development funding. Our preferred criteria for investment are: ◦Proven technology products and services ◦Corporate divestiture or private sale ◦Significant recurring revenues ◦Short decision period ◦Current revenues of $5 to $50 million ◦Quality personnel. Focus Whitehorse Capital business interests span software, hardware and associated operational and transaction management services. We have particular strengths in telecommunications and businesses serving the world's leading financial institutions. We excel at identifying, isolating and working cooperatively with owners to formulate a mutually beneficial course of action. We work swiftly and flexibly to execute transactions that allow both parties to return to their core skills and focus on honing their comparative advantage. |
Posted at 23/12/2009 04:12 by buystock WHITEHORSE take another 735k now upto over 11%,a 2.8m mkt cap have we a predator Changes in significant shareholdingsRNS Number : 5924E XCounter AB 22 December 2009 PRESS RELEASE Stockholm, 22 December 2009 XCounter notification of changes in significant shareholdings XCounter AB (AIM: XCT) ("XCounter"), a technology leader in the development of photon counting X-ray detectors and tomosynthesis based 3D medical imaging, announces today that it has received notification from Whitehorse Investing Ltd ("Whitehorse") that on the 21st December 2009 it purchased 734,786 XCounter shares taking its total shareholding to 4,834,786 shares which represents 11.1 % of XCounter. PREVIOUS RNS 2weeks ago 03 December 2009 ? PRESS RELEASE Stockholm, 03 December 2009 XCounter notification of changes in significant shareholdings XCounter AB (AIM: XCT) ("XCounter"), a technology leader in the development of photon counting X-ray detectors and tomosynthesis based 3D medical imaging, announces it has received notification from Whitehorse Investing Ltd ("Whitehorse") that it has purchased 4,100,000 XCounter shares representing 9.41 % of the issued share capital of XCounter, from HealthCap. The Company has also received notification that funds managed by HealthCap have sold in aggregate 5,476,487 XCounter shares, representing 12.57% of the share capital in XCounter. Whitehorse is an investor in a commercial partner of Oy Ajat Ltd, a company in which XCounter owns 49.8% and owns a call option for the remaining 50.2%. |
Posted at 05/2/2006 13:59 by hedgehunter Business The Times February 02, 2006 Biotechs back in favour with investors By Richard Irving THE fledgeling biotech sector burst to life yesterday as shares in the first two drug developers to raise money on the London stock market this year jumped to healthy premiums. Tom Francke, a Swedish rocket scientist, crystalised a paper fortune of just under £1.5 million after shares in his company, XCounter, soared by 25 per cent on the first day of dealings to close at 195p. Mr Francke, an astrophysicist who helped Nasa to design deep space probes to examine "Big Bang" theories, runs a company that is developing new digital three-dimensional X-ray machines using very low doses of radiation. The shares jumped 40p, making it one of the most successful biotech floats since the collapse of the hi-tech bubble in 2001. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
